Eye Journal
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option – (Eye 31, 342 (February 2017))
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option Eye 31, 342 (February 2017). doi:10.1038/eye.2016.238 Authors: D Călugăru & M Călugăru
Regenerating reptile retinas: a comparative approach to restoring retinal ganglion cell function – (Eye 31, 167 (February 2017))
Regenerating reptile retinas: a comparative approach to restoring retinal ganglion cell function Eye 31, 167 (February 2017). doi:10.1038/eye.2016.224 Author: D L Williams
Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration – (Eye 31, 173 (February 2017))
Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration Eye 31, 173 (February 2017). doi:10.1038/eye.2016.234 Author: D Fischer
Whole-eye transplantation: a look into the past and vision for the future – (Eye 31, 179 (February 2017))
Whole-eye transplantation: a look into the past and vision for the future Eye 31, 179 (February 2017). doi:10.1038/eye.2016.272 Authors: D Bourne, Y Li, C Komatsu, M R Miller, E H Davidson, L He, I A Rosner, H Tang, W Chen, M G Solari, J S Schuman & K M Washington
Why autophagy is good for retinal ganglion cells? – (Eye 31, 185 (February 2017))
Why autophagy is good for retinal ganglion cells? Eye 31, 185 (February 2017). doi:10.1038/eye.2016.278 Author: P Boya